Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

National Taiwan University

Status: Unknown

Conditions: Overactive Bladder Syndrome

Treatments: Drug: Solifenacin

Study type: Interventional

Funder types: Other

Identifiers

NCT01627145

201012024RC

Details and patient eligibility

About

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Conelations With Voiding Diary, King's Health Quentionaire, Overactive Bladder Sympton Scores and Patient Perception of Bladder Condition.

Enrollment: 300 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• female patients within 18 years old to 99 years old with overactive bladder syndrome

Exclusion criteria

• unwilling or unable to perform testing procedure

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

300 participants in 1 patient group

antimuscariniz drug

Experimental group

Treatment:

Drug: Solifenacin